Campbell & CO Investment Adviser LLC Celldex Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $675,026 - $994,332	19,166 New	19,166 $804,000
Q2 2022 Aug 09, 2022	SELL	$20.5 - $37.33 $13,120 - $23,891	-640 Reduced 7.36%	8,052 $217,000
Q1 2022 May 09, 2022	BUY	$27.64 - $39.32 $30,182 - $42,937	1,092 Added 14.37%	8,692 $296,000
Q4 2021 Feb 10, 2022	SELL	$35.68 - $56.27 $124,880 - $196,945	-3,500 Reduced 31.53%	7,600 $294,000
Q3 2021 Nov 10, 2021	BUY	$28.95 - $55.99 $89,745 - $173,569	3,100 Added 38.75%	11,100 $599,000
Q2 2021 Aug 11, 2021	BUY	$20.71 - $35.37 $165,680 - $282,960	8,000 New	8,000 $268,000

203

66M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.19B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.